Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors
- PMID: 20851870
- PMCID: PMC2995571
- DOI: 10.3324/haematol.2010.026682
Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors
Abstract
Background: Transplantation from an HLA-matched sibling is the treatment of choice for young patients with acquired severe aplastic anemia. For older patients, the acceptable upper age limit for transplantation as first-line treatment varies. The current analysis, therefore, sought to identify age or ages at transplantation at which survival differed.
Design and methods: We studied the effect of patients' age, adjusting for other significant factors affecting outcomes, in 1307 patients with severe aplastic anemia after HLA-matched sibling transplantation using logistic and Cox regression analysis. Age categories (<20 years, 20-40 years, >40 years) were determined using Martingale residual plots for overall survival and categories based on differences in survival.
Results: Patients aged over 40 years old were more likely to have had immunosuppressive therapy, a poor performance score and a longer interval between diagnosis and transplantation. Neutrophil recovery was similar in all age groups but patients aged over 40 years had a lower likelihood of platelet recovery compared to patients aged less than 20 years (OR 0.45, P=0.01) but not compared to those aged 20-40 years (OR 0.60, P=0.10). Compared to the risk of mortality in patients aged less than 20 years, mortality risks were higher in patients over 40 years old (RR 2.70, P<0.0001) and in those aged 20-40 years (RR 1.69, P<0.0001). The mortality risk was also higher in patients aged over 40 years than in those 20-40 years old (RR 1.60, P=0.008).
Conclusions: Mortality risks increased with age. Risks were also higher in patients with a poor performance score and when the interval between diagnosis and transplantation was longer than 3 months, implying earlier referral would be appropriate when this treatment option is being considered.
Figures
Similar articles
-
Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.Haematologica. 2012 Aug;97(8):1142-8. doi: 10.3324/haematol.2011.054841. Epub 2012 Feb 7. Haematologica. 2012. PMID: 22315497 Free PMC article.
-
Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia.Haematologica. 2016 May;101(5):644-52. doi: 10.3324/haematol.2015.139469. Epub 2016 Feb 8. Haematologica. 2016. PMID: 26858357 Free PMC article.
-
Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.Haematologica. 2007 May;92(5):589-96. doi: 10.3324/haematol.10899. Haematologica. 2007. PMID: 17488681
-
Bone marrow transplantation for acquired severe aplastic anemia.Hematol Oncol Clin North Am. 2014 Dec;28(6):1145-55. doi: 10.1016/j.hoc.2014.08.004. Epub 2014 Oct 5. Hematol Oncol Clin North Am. 2014. PMID: 25459184 Review.
-
[Hematopoietic stem-cell transplantation in aplastic anemia].Rev Invest Clin. 2005 Mar-Apr;57(2):298-304. Rev Invest Clin. 2005. PMID: 16524071 Review. Spanish.
Cited by
-
Etiology and survival of aplastic anemia: a study based on clinical investigation.J Clin Lab Anal. 2012 Nov;26(6):452-8. doi: 10.1002/jcla.21546. J Clin Lab Anal. 2012. PMID: 23143628 Free PMC article.
-
Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis.Haematologica. 2015 May;100(5):696-702. doi: 10.3324/haematol.2014.115345. Epub 2015 Jan 23. Haematologica. 2015. PMID: 25616576 Free PMC article.
-
Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia.Am J Hematol. 2014 Feb;89(2):125-9. doi: 10.1002/ajh.23594. Epub 2013 Nov 15. Am J Hematol. 2014. PMID: 24122901 Free PMC article.
-
[The change of quality of life in 52 patients with non-severe aplastic anemia after cyclosporine A therapy].Zhonghua Xue Ye Xue Za Zhi. 2020 Oct 14;41(10):806-810. doi: 10.3760/cma.j.issn.0253-2727.2020.10.003. Zhonghua Xue Ye Xue Za Zhi. 2020. PMID: 33190436 Free PMC article. Chinese.
-
Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research.Biol Blood Marrow Transplant. 2012 Dec;18(12):1776-84. doi: 10.1016/j.bbmt.2012.06.018. Epub 2012 Aug 1. Biol Blood Marrow Transplant. 2012. PMID: 22863842 Free PMC article.
References
-
- Marsh JC, Ball SE, Cavenagh J, Darbyshire P, Dokal I, Gordon-Smith EC, et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009;147(1):43–70. - PubMed
-
- Doney K, Leisenring W, Storb R, Appelbaum FR. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immuno-suppressive therapy. Seattle Bone Marrow Transplant Team. Ann Intern Med. 1997;126(2):107–15. - PubMed
-
- Gupta V, Marsh J. Acquired aplastic anemia and Fanconi anemia. In: Barrett J, Trealeaven J, editors. Practical Stem Cell Transplantation. 2009. pp. 165–77.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials